The United States hosted a G20 'innovation' meeting in Chapel Hill, North Carolina, where officials urged other governments to loosen constraints on artificial intelligence. ^[1] Direct obligations under Article 50 of the EU AI Act regarding the labeling of generative AI content have come into force on August 2, 2026. ^[2] The EU AI Act is entering a critical implementation phase as of August 2, 2026. ^[3] The EHDS Regulation creates a harmonized framework for the secure exchange and secondary use of electronic health data across Member States to improve patient care and foster digital health innovation. ^[4] The European Union has introduced the European Health Data Space (EHDS) Regulation as a significant step in its digital regulatory evolution, building upon the General Data Protection Regulation (GDPR) and the AI Act. ^[5] Meta's Mark Zuckerberg and Tesla's Elon Musk attended the conference and argued for fewer constraints on AI expansion, focusing on infrastructure needs. ^[6] The EU's AI Act prohibits certain AI activities deemed to pose an 'unacceptable risk' and imposes transparency standards on other AI services. ^[7] The EU AI Act provisions redefine the boundary between permissible creation and misleading practices. ^[8] Transparency regarding the origin of AI-generated and manipulated content has shifted from an ethical postulate to a hard regulatory and business standard. ^[9] Implementation of the EHDS will be phased in gradually, beginning in March 2029. ^[10] The Regulation establishes rules for the secondary use of data for purposes such as scientific research, innovation, public health, regulatory activities, and policymaking. ^[11]